lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.

[1]  T. H. van der Kwast,et al.  Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer1 , 2017, Translational oncology.

[2]  Ling Zhou,et al.  Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth , 2016, Cell Death & Disease.

[3]  Min Liu,et al.  Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. , 2016, Cancer letters.

[4]  Xixiong Kang,et al.  Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme. , 2016, Oncology reports.

[5]  Zheng Wang,et al.  A long non-coding RNA signature to improve prognosis prediction of gastric cancer , 2016, Molecular Cancer.

[6]  Jie Hong,et al.  Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma , 2016, Scientific Reports.

[7]  R. Jiang,et al.  Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways , 2016, Journal of experimental & clinical cancer research : CR.

[8]  Song Wu,et al.  New Progress of Epigenetic Biomarkers in Urological Cancer , 2016, Disease markers.

[9]  C. Weng,et al.  Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines , 2016, BMC Cancer.

[10]  Junxia Chen,et al.  Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma , 2016, Oncotarget.

[11]  Xiangjian Chen,et al.  The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer , 2016, Scientific Reports.

[12]  Y. Hua,et al.  The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer , 2016, Scientific Reports.

[13]  Chengwen Sun,et al.  Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method , 2016, Molecules.

[14]  Y. Lotan,et al.  ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms. , 2015, Cancer research.

[15]  A. Hochberg,et al.  The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision , 2015, Oncotarget.

[16]  A. Hochberg,et al.  The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory , 2015, Molecular Cancer.

[17]  P. Hwang,et al.  Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells , 2015, Marine drugs.

[18]  Zhen Jiang,et al.  Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression , 2015, Scientific Reports.

[19]  C. Brocker,et al.  Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. , 2015, Biochimica et biophysica acta.

[20]  Guoxin Zhang,et al.  The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer , 2015, Cellular Physiology and Biochemistry.

[21]  Lihua Cao,et al.  Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. , 2015, Oncology letters.

[22]  Li Zhang,et al.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer , 2015, Oncotarget.

[23]  C. Klumb,et al.  Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. , 2015, Experimental and molecular pathology.

[24]  H. Yao,et al.  A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.

[25]  Yunliang Gao,et al.  Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancer , 2015, OncoTargets and therapy.

[26]  J. Catto,et al.  Identification of Differentially Expressed Long Noncoding RNAs in Bladder Cancer , 2014, Clinical Cancer Research.

[27]  Y. Kondo,et al.  Involvement of miRNA‐29a in epigenetic regulation of transforming growth factor‐β‐induced epithelial–mesenchymal transition in hepatocellular carcinoma , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[28]  A. Hochberg,et al.  Oncofetal H19 RNA promotes tumor metastasis. , 2014, Biochimica et biophysica acta.

[29]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[30]  F. Wang,et al.  MicroRNA-29b regulates TGF-β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells by targeting AKT2. , 2014, Experimental cell research.

[31]  C. Scheel,et al.  Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer , 2014, Oncotarget.

[32]  Yun Liu,et al.  Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition , 2014, Diagnostic Pathology.

[33]  S. Serrano,et al.  LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk , 2014, British Journal of Cancer.

[34]  Xiaoshan Feng,et al.  Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma , 2014, Molecular Genetics and Genomics.

[35]  Chaochun Liu,et al.  The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.

[36]  Wun-Jae Kim,et al.  Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target , 2013, Korean journal of urology.

[37]  T. Ochiya,et al.  miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases , 2013, International journal of molecular sciences.

[38]  C. Croce,et al.  Hepatic miR-29ab1 expression modulates chronic hepatic injury , 2012, Journal of cellular and molecular medicine.

[39]  Y. Xin,et al.  Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells. , 2012, The international journal of biochemistry & cell biology.

[40]  P. Mortensen.  EPIDEMIOLOGY , 2012, Schizophrenia Research.

[41]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[42]  A. Shiras,et al.  Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas , 2011, Journal of Neuro-Oncology.

[43]  Wei Zhang,et al.  miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma , 2010, Genes, chromosomes & cancer.

[44]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[45]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[46]  Shouhua Wang,et al.  Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. , 2016, American journal of cancer research.

[47]  H. Salehiniya,et al.  Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[48]  刘刚,et al.  Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma , 2014 .